■除了药物治疗,建议采用心理治疗方法治疗纤维肌痛。有人建议,眼球运动脱敏和后处理(EMDR)治疗可能是有效的。本研究旨在探讨EMDR治疗对纤维肌痛症状的影响,抑郁症,睡眠质量,通过随机对照研究(RCT),纤维肌痛患者的创伤应激。
本研究的样本包括79名诊断为纤维肌痛的个体。参与者被随机分为两组:“照常治疗”(TAU)组和TAUEMDR组。在研究之前和六个不同的时间点(在开始研究之前,在5号结束的时候,第十,第十五届会议,一个月后,3个月后),参与者完成了评估,包括纤维肌痛影响问卷(FIQ),视觉模拟量表(VAS),纤维肌痛ACR2010诊断标准[广泛疼痛指数(WPI)和症状严重程度量表(SSS)],贝克抑郁量表(BDI),匹兹堡睡眠质量指数(PSQI)和创伤症状清单-40(TSC-40)。
■研究组和实验组之间的社会人口统计学变量没有差异。方差分析显示,对VAS有统计学意义的群体效应(p=0.019),WPI(p=0.018),BDI(p=0.019),和TSC-40(p=0.21)。在应用Bonferroni校正后,发现EMDR对VAS有效,WPI,SSS,BDI,PSQI,和TSC-40(p<0.05)。
■当前研究的结果表明,EMDR疗法是纤维肌痛的可行替代疗法。我们相信这些发现提供了有力的证据支持EMDR疗法治疗纤维肌痛的疗效。特别是在随机对照试验(RCT)的背景下。应用EMDR疗法治疗纤维肌痛患者可能是有益的。
■ClinicalTrials.gov,标识符NCT06265194。
UNASSIGNED: In addition to pharmacological treatment, psychotherapeutic approaches are recommended for the treatment of fibromyalgia. There is a suggestion that eye movement desensitization and reprocessing (
EMDR) therapy may be effective. This study aimed to investigate the impact of
EMDR therapy on fibromyalgia symptoms, depression, sleep quality, and traumatic stress in fibromyalgia patients through a randomized controlled study (RCT).
UNASSIGNED: The sample for this study comprised 79 individuals diagnosed with fibromyalgia. Participants were randomly assigned to two groups: the \"Treatment as Usual\" (TAU) group and the TAU +
EMDR group. Prior to the study and at six different time points (before starting the study, at the end of the 5th, 10th, and 15th sessions, 1 month later, and 3 months later), participants completed assessments, including the Fibromyalgia Impact Questionnaire (FIQ), Visual Analog Scale (VAS), Fibromyalgia ACR 2010 Diagnostic Criteria [Widespread Pain Index (WPI) and Symptom Severity Scale (SSS)], Beck Depression Inventory (BDI), Pittsburgh Sleep Quality Index (PSQI), and Trauma Symptom Checklist-40 (TSC-40).
UNASSIGNED: There were no differences in the sociodemographic variables between the study and experimental groups. Analysis of variance revealed a statistically significant group effect on VAS (p = 0.019), WPI (p = 0.018), BDI (p = 0.019), and TSC-40 (p = 0.21). After applying Bonferroni correction,
EMDR was found to be effective for VAS, WPI, SSS, BDI, PSQI, and TSC-40 (p <0.05).
UNASSIGNED: The results of the current study suggest that
EMDR therapy is a viable alternative treatment for fibromyalgia. We believe these findings offer robust evidence supporting the efficacy of EMDR therapy in treating fibromyalgia, particularly in the context of a randomized controlled trial (RCT). The application of EMDR therapy for the treatment of patients with fibromyalgia is likely to be beneficial.
UNASSIGNED: ClinicalTrials.gov, identifier NCT06265194.